CAC (gated) Algorithm vs cmAngio®
AI Verdict
Choose CAC (gated) Algorithm if…
Choose the CAC (gated) Algorithm if your primary goal is a precise, quantitative assessment of coronary artery calcium directly from ECG-gated cardiac CT scans. This tool is ideal for physicians needing to accurately quantify CAC to assess coronary artery health and support cardiovascular disease risk stratification based on dedicated cardiac imaging.
View CAC (gated) Algorithm →Choose cmAngio® if…
Choose cmAngio® if you aim to opportunistically screen for cardiovascular risk in women by leveraging existing mammography exams to detect Breast Arterial Calcifications (BAC). This solution is best suited for integrating cardiovascular insights into routine breast imaging workflows without requiring additional patient procedures or radiation exposure.
View cmAngio® →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CAC (gated) Algorithm | cmAngio® |
|---|---|---|
| Pricing | Unknown | Paid, out-of-pocket |
| Deployment | Unknown | Cloud-based, integrates with any DICOM-compliant viewer |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CAC (gated) AlgorithmTool A integrates into physicians' standard workflows and pre-populates structured reports for radiologist review and approval, directly streamlining the reporting process. While Tool B offers quick installation and DICOM compatibility, Tool A's direct impact on report generation provides a more significant usability advantage in daily clinical practice.
Clinical Value
CAC (gated) AlgorithmTool A detects and quantifies coronary artery calcium (CAC) from ECG-gated cardiac CT scans, which is a direct and well-established marker for assessing coronary artery disease risk. Tool B detects Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health as an opportunistic finding. While both offer clinical value, CAC is a more primary and widely accepted indicator of cardiovascular disease risk.
Pricing & Value
cmAngio®Both tools require contacting the vendor for pricing details, making direct comparison difficult. However, Tool B explicitly mentions 'limited-time offers for no-cost implementation and service' which, if available, could offer a significant initial value proposition over Tool A's undisclosed pricing.
Enterprise Readiness
CAC (gated) AlgorithmBoth tools are FDA-cleared and HIPAA compliant. Tool A explicitly states it 'has_baa: yes', whereas Tool B requires contacting the vendor for BAA details, which adds a step. Furthermore, Tool A is described as 'Part of the broader Carebricks platform for AI-powered workflows', suggesting a more robust and integrated enterprise solution for scalability and broader application within a health system.
Innovation
CAC (gated) AlgorithmTool A's tagline 'Generative AI for clinical reasoning and action' and its integration into the 'Carebricks' platform, which enables health systems to build AI agents for automated workflows and clinical reasoning, suggests a more advanced and broader application of AI beyond just detection and quantification. This represents a higher level of innovation in AI methodology and potential impact on clinical workflows compared to Tool B's focus on BAC detection and scoring from existing mammograms.
Support & Docs
cmAngio®While both companies offer contact information for support, Tool B explicitly refers to an 'Operator's Manual' for additional details, indicating readily available product-specific documentation. Tool A's information includes a 'Trust Center' and general contact details, but no explicit mention of product manuals.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CAC (gated) Algorithm | cmAngio® |
|---|---|---|
| Product Name | CAC (gated) Algorithm | cmAngiou00ae |
| Company | BunkerHill Health | CureMetrix |
| Description | AI software that automatically detects and quantifies coronary artery calcium from non-contrast ECG-gated cardiac CT scans, aiding physicians in assessing coronary artery health. | FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. |
| Key Features | Automatic detection and quantification of coronary artery calcium (CAC); Analysis of non-contrast ECG-gated cardiac CT scans; Provides calcium segmentation and quantification; Integrates into physicians' standard workflow; Pre-populates structured reports for radiologist review and approval; Aids in assessing coronary artery health; Supports opportunistic detection of cardiovascular disease; Part of the broader Carebricks platform for AI-powered workflows. | AI-based detection of Breast Arterial Calcifications (BAC); Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams; Provides visualization of BAC location on a scorecard; Enables BAC identification and reporting without additional radiation or procedures; Compatible with any DICOM-compliant viewer; Adjustable operating point to meet clinical goals; Quick and easy installation (less than an hour); Cybersecure and HIPAA-compliant. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, OB/GYN AI, Radiology & Imaging AI |
| Specialties | Cardiology, Radiology | Cardiology, Obstetrics & Gynecology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring CAC (gated) Algorithm and cmAngio®.